424 related articles for article (PubMed ID: 32567459)
1. Prognostic Significance of the Controlling Nutritional Status (CONUT) Score in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab after Failure of Prior Tyrosine Kinase Inhibitors.
Takemura K; Yuasa T; Fujiwara R; Ito M; Suzuki H; Yonese J; Koga F
J Urol; 2020 Dec; 204(6):1166-1172. PubMed ID: 32567459
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
Xue W; Zhang Y; Wang H; Zhang Y; Hu X
Front Immunol; 2021; 12():778746. PubMed ID: 34917092
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients.
Suzuki H; Ito M; Takemura K; Nakanishi Y; Kataoka M; Sakamoto K; Tobisu KI; Koga F
Urol Oncol; 2020 Mar; 38(3):76.e11-76.e17. PubMed ID: 31864938
[TBL] [Abstract][Full Text] [Related]
4. Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.
Elghiaty A; Kim J; Jang WS; Park JS; Heo JE; Rha KH; Choi YD; Ham WS
J Cancer Res Clin Oncol; 2019 Apr; 145(4):957-965. PubMed ID: 30758671
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Nutritional Status Assessed by the Controlling Nutritional Status (CONUT) Score in Patients with Surgically Treated Renal Cell Carcinoma.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Hoe Kim H; Kwak C; Byun SS; Kim YJ;
Nutr Cancer; 2018; 70(6):886-894. PubMed ID: 30235010
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure.
Iwakami N; Nagai T; Furukawa TA; Sugano Y; Honda S; Okada A; Asaumi Y; Aiba T; Noguchi T; Kusano K; Ogawa H; Yasuda S; Anzai T;
Int J Cardiol; 2017 Mar; 230():529-536. PubMed ID: 28041709
[TBL] [Abstract][Full Text] [Related]
7. Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy.
Daitoku N; Miyamoto Y; Tokunaga R; Sakamoto Y; Hiyoshi Y; Iwatsuki M; Baba Y; Iwagami S; Yoshida N; Baba H
Anticancer Res; 2018 Aug; 38(8):4883-4888. PubMed ID: 30061264
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the Controlling Nutritional Status score following curative nephrectomy for patients with renal cell carcinoma.
Zheng Y; Bao L; Wang W; Wang Q; Pan Y; Gao X
Medicine (Baltimore); 2018 Dec; 97(49):e13409. PubMed ID: 30544418
[TBL] [Abstract][Full Text] [Related]
9. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.
Yılmaz A; Tekin SB; Bilici M; Yılmaz H
Lung; 2020 Aug; 198(4):695-704. PubMed ID: 32424800
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer.
Li Y; Zhang C; Ji R; Lu H; Zhang W; Li LL; Liu R; Qian H; He A
Int J Gynecol Cancer; 2020 Jan; 30(1):74-82. PubMed ID: 31822507
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of controlling nutritional status score (CONUT) in evaluating outcome of postoperative patients with gastric cancer.
Xiao Q; Li X; Duan B; Li X; Liu S; Xu B; Shi S; Zhang J; Qin H; Duan X; Pu Y
Sci Rep; 2022 Jan; 12(1):93. PubMed ID: 34997105
[TBL] [Abstract][Full Text] [Related]
12. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma.
Yamamoto Y; Matsuyama H; Matsumoto H; Sakano S; Fuji N; Oba K; Yamamoto M; Kamiryo Y; Hiragino T; Nagao K; Takai K; Aoki A
Jpn J Clin Oncol; 2020 Feb; 50(2):214-220. PubMed ID: 31755525
[TBL] [Abstract][Full Text] [Related]
14. Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab.
Zahoor H; Barata PC; Jia X; Martin A; Allman KD; Wood LS; Gilligan TD; Grivas P; Ornstein MC; Garcia JA; Rini BI
J Immunother Cancer; 2018 Oct; 6(1):107. PubMed ID: 30333065
[TBL] [Abstract][Full Text] [Related]
15. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
Zhang Y; Kong FF; Zhu ZQ; Shan HX
BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy in renal cell carcinoma: is resection still solely enough?
Gharib KE
Future Oncol; 2021 Feb; 17(6):633-636. PubMed ID: 33305597
[No Abstract] [Full Text] [Related]
17. A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy.
Ornstein MC; Wood LS; Hobbs BP; Allman KD; Martin A; Bevan M; Gilligan TD; Garcia JA; Rini BI
J Immunother Cancer; 2019 May; 7(1):127. PubMed ID: 31097024
[TBL] [Abstract][Full Text] [Related]
18. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
[TBL] [Abstract][Full Text] [Related]
19. The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study.
Guven DC; Acar R; Yekeduz E; Bilgetekin I; Baytemur NK; Erol C; Ceylan F; Sendur MA; Demirci U; Urun Y; Karadurmus N; Erman M; Kilickap S
Curr Probl Cancer; 2021 Dec; 45(6):100760. PubMed ID: 34130864
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab.
Roussel E; Kinget L; Verbiest A; Debruyne PR; Baldewijns M; Van Poppel H; Albersen M; Beuselinck B
Urol Oncol; 2021 Apr; 39(4):239.e17-239.e25. PubMed ID: 33485762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
